Approaches to monitoring intussusception following rotavirus vaccination

References

• Midthun K, Kapikian AZ. Rotavirus vaccines: an overview. Clin Microbiol Rev. 1996;9:423–434.
   PubMed Web of Science ®Google Scholar
• Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1999;48:1–20.
   Google Scholar
• Joensuu J, Koskenniemi E, Vesikari T. Symptoms associated with rhesus-human reassortant rotavirus vaccine in infants. Pediatr Infect Dis J. 1998;17:334–340.
   PubMed Web of Science ®Google Scholar
• Murphy TV, Gargiullo PM, Massoudi MS, et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med. 2001;344:564–572.
   PubMed Web of Science ®Google Scholar
• Kramarz P, France EK, Destefano F, et al. Population-based study of rotavirus vaccination and intussusception. Pediatr Infect Dis J. 2001;20:410–416.
   PubMed Web of Science ®Google Scholar
• Centers for Disease C, Prevention. Withdrawal of rotavirus vaccine recommendation. MMWR Morb Mortal Wkly Rep. 1999;48:1007.
   PubMedGoogle Scholar
• Peter G, Myers MG, National Vaccine Advisory C, National Vaccine Program O. Intussusception, rotavirus, and oral vaccines: summary of a workshop. Pediatrics. 2002;110:e67.
   PubMed Web of Science ®Google Scholar
• Rennels MB, Parashar UD, Holman RC, et al. Lack of an apparent association between intussusception and wild or vaccine rotavirus infection. Pediatr Infect Dis J. 1998;17:924–925.
   PubMed Web of Science ®Google Scholar
• Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354:11–22.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354:23–33.
   PubMed Web of Science ®Google Scholar
• Armah GE, Sow SO, Breiman RF, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2010;376:606–614.
   PubMed Web of Science ®Google Scholar
• Madhi SA, Cunliffe NA, Steele D, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med. 2010;362:289–298.
   PubMed Web of Science ®Google Scholar
• Zaman K, Dang DA, Victor JC, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet. 2010;376:615–623.
   PubMed Web of Science ®Google Scholar
• Bhandari N, Rongsen-Chandola T, Bavdekar A, et al. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial. Lancet. 2014;383:2136–2143.
   PubMed Web of Science ®Google Scholar
• Isanaka S, Guindo O, Langendorf C, et al. Efficacy of a low-cost, heat-stable oral rotavirus vaccine in niger. N Engl J Med. 2017;376:1121–1130.
   PubMed Web of Science ®Google Scholar
• Kulkarni PS, Desai S, Tewari T, et al. A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants. Vaccine. 2017;35:6228–6237.
   PubMed Web of Science ®Google Scholar
• Centers for Disease C, Prevention. Intussusception among recipients of rotavirus vaccine–United States, 1998–1999. MMWR Morb Mortal Wkly Rep. 1999;48(27): 577–581.
   PubMedGoogle Scholar
• Haber P, Patel M, Izurieta HS, et al. Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007. Pediatrics. 2008;121:1206–1212.
   PubMed Web of Science ®Google Scholar
• Haber P, Patel M, Pan Y, et al. Intussusception after rotavirus vaccines reported to US VAERS, 2006–2012. Pediatrics. 2013;131:1042–1049.
   PubMed Web of Science ®Google Scholar
• Haber P, Parashar UD, Haber M, et al. Intussusception after monovalent rotavirus vaccine-United States, Vaccine Adverse Event Reporting System (VAERS), 2008–2014. Vaccine. 2015;33:4873–4877.
   PubMed Web of Science ®Google Scholar
• Escolano S, Hill C, Tubert-Bitter P. Intussusception risk after RotaTeq vaccination: evaluation from worldwide spontaneous reporting data using a self-controlled case series approach. Vaccine. 2015;33:1017–1020.
   PubMed Web of Science ®Google Scholar
• Weintraub ES, Baggs J, Duffy J, et al. Risk of intussusception after monovalent rotavirus vaccination. N Engl J Med. 2014;370:513–519.
   PubMed Web of Science ®Google Scholar
• Yih WK, Lieu TA, Kulldorff M, et al. Intussusception risk after rotavirus vaccination in U.S. infants. N Engl J Med. 2014;370:503–512.
   PubMed Web of Science ®Google Scholar
• Belongia EA, Irving SA, Shui IM, et al. Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine. Pediatr Infect Dis J. 2010;29:1–5.
   PubMed Web of Science ®Google Scholar
• Patel MM, Lopez-Collada VR, Bulhoes MM, et al. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med. 2011;364:2283–2292.
   PubMed Web of Science ®Google Scholar
• Carlin JB, Macartney KK, Lee KJ, et al. Intussusception risk and disease prevention associated with rotavirus vaccines in Australia’s National immunization program. Clin Infect Dis. 2013;57:1427–1434.
   PubMed Web of Science ®Google Scholar
• Whitaker HJ, Hocine MN, Farrington CP. The methodology of self-controlled case series studies. Stat Methods Med Res. 2009;18:7–26.
   PubMed Web of Science ®Google Scholar
• Stowe J, Andrews N, Ladhani S, et al. The risk of intussusception following monovalent rotavirus vaccination in England: A self-controlled case-series evaluation Ref. No: JVAC-D-16-01124. Vaccine. 2016;34:6115.
   PubMed Web of Science ®Google Scholar
• Velazquez FR, Colindres RE, Grajales C, et al. Postmarketing surveillance of intussusception following mass introduction of the attenuated human rotavirus vaccine in Mexico. Pediatr Infect Dis J. 2012;31:736–744.
   PubMed Web of Science ®Google Scholar
• Yung CF, Chan SP, Soh S, et al. Intussusception and monovalent rotavirus vaccination in Singapore: self-controlled case series and risk-benefit study. J Pediatr. 2015;167:163–8e1.
   PubMed Web of Science ®Google Scholar
• Tate JE, Mwenda JM, Armah G, et al. Evaluation of intussusception after monovalent rotavirus vaccination in Africa. N Engl J Med. 2018;378:1521–1528.
   PubMed Web of Science ®Google Scholar
• Quinn HE, Wood NJ, Cannings KL, et al. Intussusception after monovalent human rotavirus vaccine in Australia: severity and comparison of using healthcare database records versus case confirmation to assess risk. Pediatr Infect Dis J. 2014;33:959–965.
   PubMed Web of Science ®Google Scholar
• Stowe J, Andrews N, Ladhani S, et al. The risk of intussusception following monovalent rotavirus vaccination in England: A self-controlled case-series evaluation. Vaccine. 2016;34:3684–3689.
   PubMed Web of Science ®Google Scholar
• Simonsen L, Morens D, Elixhauser A, et al. Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception. Lancet. 2001;358:1224–1229.
   PubMed Web of Science ®Google Scholar
• Tate JE, Yen C, Steiner CA, et al. Intussusception rates before and after the introduction of rotavirus vaccine. Pediatrics. 2016;138(3):pii: e20161082. doi:10.1542/peds.2016-1082. Epub 2016 Aug 24.
   Web of Science ®Google Scholar
• Yen C, Tate JE, Steiner CA, et al. Trends in intussusception hospitalizations among US infants before and after implementation of the rotavirus vaccination program, 2000–2009. J Infect Dis. 2012;206:41–48.
   PubMed Web of Science ®Google Scholar
• Farrington CP, Whitaker HJ, Hocine MN. Case series analysis for censored, perturbed, or curtailed post-event exposures. Biostatistics. 2009;10:3–16.
   PubMed Web of Science ®Google Scholar
• Burnett E, Jonesteller CL, Tate JE, et al. Global impact of rotavirus vaccination on childhood hospitalizations and mortality from diarrhea. J Infect Dis. 2017;215:1666–1672.
   PubMed Web of Science ®Google Scholar
• Rotavirus vaccines. WHO position paper - January 2013. Wkly Epidemiol Rec. 2013;88:49–64.
   PubMedGoogle Scholar
• World Health Organization. Rotavirus vaccines. Wkly Epidemiol Rec. 2007;82:285–295.
   PubMedGoogle Scholar
• Kirkwood CD, Ma LF, Carey ME, et al. The rotavirus vaccine development pipeline. Vaccine. 2017:pii: S0264-410X(17)30410-3. doi:10.1016/j.vaccine.2017.03.076. Epub ahead of print.
   Web of Science ®Google Scholar